publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
http
infectionthelancetcom
vol
juli
adimora
schoenbach
v
social
context
sexual
network
racial
dispar
rate
sexual
transmit
infect
j
infect
di
suppl
open
address
fi
rst
lancet
asia
medic
forum
prepar
pandem
infl
uenza
avian
dimens
emerg
threat
singapor
may
kandiah
satkunanantham
director
medic
servic
singapor
ministri
health
fi
gure
call
cooper
among
nation
aff
ect
avian
infl
uenza
share
critic
inform
beggar
thi
neighbour
approach
thij
kuiken
erasmu
univers
rotterdam
netherland
describ
highli
pathogen
avian
infl
uenza
hpai
predominantli
diseas
poultri
rare
aff
ect
speci
mutat
low
pathogen
lpai
virus
whose
natur
reservoir
wild
waterbird
hpai
form
occur
poultri
virus
haemagglutinin
type
caus
highli
pathogen
diseas
increas
size
hpai
outbreak
past
decad
due
growth
poultri
industri
billion
chicken
billion
duck
rear
worldwid
kuiken
identifi
ed
unusu
aspect
current
outbreak
direct
transmiss
bird
human
be
mammal
result
sever
diseas
system
diseas
human
be
mammal
freeliv
bird
mode
viru
spread
without
evid
link
poultri
hiroshi
kida
hokkaido
univers
sapporo
japan
note
duck
viru
replic
intestin
therefor
antibodi
select
pressur
thu
migratori
duck
maintain
apathogen
infl
uenza
virus
infect
chicken
passag
gees
turkey
quail
lead
lpai
infect
chicken
henc
mutat
hpai
kida
note
pandem
virus
reassort
avian
virus
preced
human
strain
thu
avian
virus
subtyp
contribut
gene
reassort
none
haemagglutinin
nine
neuraminidas
subtypesal
occur
duckscan
rule
potenti
candid
futur
pandem
kennedi
shortridg
univers
hong
kong
hong
kong
sar
china
wonder
nt
pandem
everi
year
southern
china
abound
infl
uenza
viru
better
understand
genet
molecular
marker
antigen
featur
infl
uenza
viru
might
answer
question
shortridg
believ
make
prevent
pandem
achiev
object
shortridg
also
note
spread
asia
follow
transsiberia
railway
rather
know
pattern
wildbird
migrat
thu
probabl
result
human
movement
poultri
poultri
product
vietnam
one
countri
worst
aff
ect
nguyen
tran
hien
nation
institut
hygien
epidemiolog
hanoi
vietnam
describ
human
diseas
occur
three
wave
dec
nov
time
human
case
death
case
fatal
rate
million
poultri
kill
incub
period
human
infect
rang
day
median
day
howev
new
human
poultri
case
sinc
nov
hien
recommend
avian
infl
uenza
consid
combin
agricultur
public
health
econom
social
threat
outbreak
thailand
also
occur
three
wave
nov
dec
result
lancet
forum
prepar
pandem
infl
uenza
human
case
death
accord
kumnuan
ungchusak
ministri
public
health
nonthaburi
thailand
complac
caus
repeat
outbreak
polit
committ
second
wave
eventu
key
tackl
outbreak
malik
peiri
univers
hong
kong
hong
kong
sar
china
note
human
diseas
qualit
diff
erent
diseas
caus
virus
patient
die
primarili
acut
respiratori
distress
syndrom
respiratori
failur
specul
infect
lower
respiratori
epithelium
lead
hyperinduct
chemokin
attract
macrophag
infi
ltrate
lung
induct
proinfl
ammatori
cytokin
henc
characterist
immunopatholog
jame
campbel
univers
maryland
center
vaccin
develop
baltimor
md
usa
describ
human
trial
usa
sanofi
pasteur
inactiv
subunit
vaccin
vaccin
viru
grown
egg
formaldehyd
kill
given
intramuscular
inject
process
produc
season
infl
uenza
vaccin
use
extens
experi
vaccin
likelihood
rapid
licensur
among
healthi
volunt
given
two
dose
vaccin
order
magnitud
lower
antibodi
titr
compar
season
fl
u
vaccin
volunt
given
highest
vaccin
dose
three
six
time
season
vaccin
dose
substanti
antibodi
titr
also
describ
result
safeti
immunogen
trial
sanofi
pasteur
vaccin
melani
savil
sanofi
pasteur
lyon
franc
vaccin
given
one
three
diff
erent
dose
without
alum
adjuv
healthi
adult
volunt
franc
vaccin
produc
seriou
advers
event
two
dose
plu
alum
adjuv
given
day
apart
requir
produc
antibodi
respons
particip
accord
martin
deni
glaxosmithklin
gsk
biolog
rixensart
belgium
worldwid
manufactur
capac
infl
uenza
vaccin
million
dose
per
year
howev
reduc
amount
antigen
dose
would
allow
dose
gsk
work
adjuv
boost
immun
respons
combin
lower
amount
antigen
clinic
trial
ongo
inactiv
subunit
vaccin
use
gsk
adjuv
anim
studi
adjuv
give
cross
protect
vaccin
one
viral
strain
challeng
anoth
impli
stockpil
vaccin
may
feasibl
even
know
advanc
pandem
strain
viru
review
pandem
antivir
drug
option
frederick
hayden
univers
virginia
health
scienc
center
charlottesvil
va
usa
global
infl
uenza
programm
geneva
switzerland
fi
gure
state
longterm
prophylaxi
ineffi
cient
use
limit
drug
suppli
howev
target
geograph
prophylaxi
neuraminidas
inhibitor
eg
oseltamivir
might
succeed
contain
delay
emerg
pandem
hayden
also
conclud
concern
develop
resist
neuraminidas
inhibitor
deterr
stockpil
drug
multicentr
randomis
trial
southeast
asia
compar
standard
higher
dose
oseltamivir
hospitalis
patient
diseas
sever
infl
uenza
inject
antivir
need
help
control
futur
infl
uenza
outbreak
hayden
note
trial
progress
inject
form
zanamivir
investig
neuraminidas
inhibitor
peramivir
david
reddi
f
hoff
manla
roch
ltd
basel
switzerland
explain
build
oseltamivir
stockpil
necessari
possibl
respond
emerg
surg
product
capac
due
long
lead
time
manufactur
drug
product
capac
oseltamivir
increas
million
cours
million
cours
roch
donat
million
cours
oseltamivir
global
region
stockpil
compani
receiv
order
letter
intent
nation
stockpil
countri
nation
stockpil
suffi
cient
treat
popul
could
prevent
hospit
admiss
reduc
death
event
pandem
reddi
note
past
pandem
attack
rate
reach
describ
prepared
plan
infl
uenza
pandem
jai
narain
region
offi
ce
southeast
asia
new
delhi
india
emphasis
key
role
nation
prepared
plan
plan
test
refi
ned
mock
drill
tabletop
exercis
narain
state
collabor
among
anim
human
health
agenc
vital
warn
ministri
countri
respond
threat
pandem
accord
roy
anderson
imperi
colleg
london
uk
intuit
decid
best
option
pandem
control
must
must
calcul
model
allow
eff
ectiv
variou
pandem
control
measur
test
exampl
close
school
would
slow
spread
diseas
must
done
fi
rst
week
two
nation
epidem
vaccin
populationassum
eff
ectiv
vaccin
availablecould
stop
spread
nation
epidem
howev
close
border
would
eff
ectiv
impact
control
countri
epidem
david
bell
center
diseas
control
prevent
atlanta
ga
usa
note
sever
acut
respiratori
syndrom
sar
outbreak
among
million
intern
travel
thermal
scan
sar
case
detect
howev
infl
uenza
pandem
nonessenti
domest
travel
aff
ect
area
discourag
bell
state
forc
isol
quarantin
like
ineff
ectiv
ill
patient
encourag
stay
home
wherea
suffi
cient
evid
recommend
use
mask
public
hand
hygien
lower
rate
upperrespiratorytract
infect
martin
meltzer
center
diseas
control
prevent
atlanta
ga
usa
estim
infl
uenza
pandem
might
cost
usa
around
billion
produc
reduct
econom
demand
asia
howev
emphasis
estim
base
littl
data
meltzer
state
event
pandem
believ
countri
world
readili
absorb
need
hospit
offi
cebas
medic
care
infl
uenza
surveil
integr
part
pandem
prepared
accord
lanc
jen
canterburi
health
laboratori
christchurch
new
zealand
howev
sampl
collect
annual
million
billion
infl
uenza
case
jen
describ
current
standard
surveil
dark
age
summaris
gap
pandem
prepared
robert
webster
st
jude
children
research
hospit
memphi
tn
usa
describ
worst
fl
u
viru
ever
seen
suggest
minimum
ten
mutat
requir
humantohuman
transmiss
webster
call
develop
wholeviru
vaccin
stockpil
identifi
ed
gap
plan
implement
plan
crucial
issu
must
address
lancet
infecti
diseas
jamestown
road
london
uk
